Cite Filings / STLN / 0001013762-25-004366

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Starling Oncology, Inc. Filed 2025-03-28 Acc 0001013762-25-004366

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-04-23 SCHEDULE 13D/A Beneficial Ownership Report
2025-03-28 4 Chief Executive Officer bought 22,640 shares at $1.04 ($23,584)
2025-03-28 4 Chief Medical Officer bought 9,056 shares at $1.04 ($9,434)
2025-03-28 4 Director bought 90,562 shares at $1.04 ($94,338)
2025-03-28 4 Director bought 36,224 shares at $1.04 ($37,735)
2025-03-28 SCHEDULE 13D/A Beneficial Ownership Report
2025-03-28 4 Director acquired 2,716,898 shares (grant or award)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…